The promise of metabolic phenotyping in gastroenterology and hepatology (original) (raw)

• Nicholson, J. K. Global systems biology, personalized medicine and molecular epidemiology. Mol. Syst. Biol. 2, 52 (2006).
  Article PubMed PubMed Central Google Scholar
• Ogino, S. et al. Interdisciplinary education to integrate pathology and epidemiology: towards molecular and population-level health science. Am. J. Epidemiol. 176, 659–667 (2012).
  Article PubMed PubMed Central Google Scholar
• Kalow, W. Pharmacogenetics and personalised medicine. Fundam. Clin. Pharmacol. 16, 337–342 (2002).
  Article CAS PubMed Google Scholar
• Nicholson, J. K. et al. Metabolic phenotyping in clinical and surgical environments. Nature 491, 384–392 (2012).
  Article CAS PubMed Google Scholar
• Holmes, E., Wilson, I. D. & Nicholson, J. K. Metabolic phenotyping in health and disease. Cell 134, 714–717 (2008).
  Article CAS PubMed Google Scholar
• Hood, L., Balling, R. & Auffray, C. Revolutionizing medicine in the 21st century through systems approaches. Biotechnol. J. 7, 992–1001 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Pimiento, J. M. et al. Melanoma genotypes and phenotypes get personal. Lab. Invest. 93, 858–867 (2013).
  Article PubMed Google Scholar
• Nicholson, J. K., Holmes, E. & Wilson, I. D. Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 3, 431–438 (2005).
  Article CAS PubMed Google Scholar
• Salazar, N. et al. Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. Clin. Nutr. 34, 501-507 (2014).
  Article CAS PubMed Google Scholar
• Faith, J. J., Ahern, P. P., Ridaura, V. K., Cheng, J. & Gordon, J. I. Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci. Transl. Med. 6, 220ra11 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Borgan, E. et al. Subtype-specific response to bevacizumab is reflected in the metabolome and transcriptome of breast cancer xenografts. Mol. Oncol. 7, 130–142 (2013).
  Article CAS PubMed Google Scholar
• Robinette, S. L., Lindon, J. C. & Nicholson, J. K. Statistical spectroscopic tools for biomarker discovery and systems medicine. Anal. Chem. 85, 5297–5303 (2013).
  Article CAS PubMed Google Scholar
• Ciccarelli, O. et al. Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging. Lancet Neurol. 13, 807–822 (2014).
  Article CAS PubMed Google Scholar
• Woo, J., Baumann, A. & Arguello, V. Recent advancements of flow cytometry: new applications in hematology and oncology. Expert Rev. Mol. Diagn. 14, 67–81 (2014).
  Article CAS PubMed Google Scholar
• Wang, Y. W. et al. Rapid ratiometric biomarker detection with topically applied SERS nanoparticles. Technology (Singap. World Sci.) 2, 118–132 (2014).
  Google Scholar
• Holmes, E. et al. Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453, 396–400 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Whiley, L. et al. Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease. Neurobiol. Aging 35, 271–278 (2014).
  Article CAS PubMed Google Scholar
• Maher, A. D. et al. Optimization of human plasma 1H NMR spectroscopic data processing for high-throughput metabolic phenotyping studies and detection of insulin resistance related to type 2 diabetes. Anal. Chem. 80, 7354–7362 (2008).
  Article CAS PubMed Google Scholar
• Hazen, S. L. New lipid and lipoprotein targets for the treatment of cardiometabolic diseases. J. Lipid. Res. 53, 1719–1721 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Cooper-Dehoff, R. M. et al. Is diabetes mellitus-linked amino acid signature associated with β-blocker-induced impaired fasting glucose? Circ. Cardiovasc. Genet. 7, 199–205 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Shariff, M. I. et al. Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study. J. Proteome Res. 10, 1828–1836 (2011).
  Article CAS PubMed Google Scholar
• Nicholson, J. K., Everett, J. R. & Lindon, J. C. Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy. Expert Opin. Drug Metab. Toxicol. 8, 135–139 (2012).
  Article CAS PubMed Google Scholar
• Klootwijk, E. D. et al. Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome. N. Engl. J. Med. 370, 129–138 (2014).
  Article CAS PubMed Google Scholar
• Pan, Z. et al. Principal component analysis of urine metabolites detected by NMR and DESI-MS in patients with inborn errors of metabolism. Anal. Bioanal. Chem. 387, 539–549 (2007).
  Article CAS PubMed Google Scholar
• Plumb, R. et al. Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. Rapid Commun. Mass. Spectrom. 18, 2331–2337 (2004).
  Article CAS PubMed Google Scholar
• Shockcor, J. P. et al. Combined HPLC, NMR spectroscopy, and ion-trap mass spectrometry with application to the detection and characterization of xenobiotic and endogenous metabolites in human urine. Anal. Chem. 68, 4431–4435 (1996).
  Article CAS PubMed Google Scholar
• Duarte, I. F., Lamego, I., Rocha, C. & Gil, A. M. NMR metabonomics for mammalian cell metabolism studies. Bioanalysis 1, 1597–1614 (2009).
  Article CAS PubMed Google Scholar
• Jimenez, B. et al. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic “field-effects” enables colorectal cancer staging and prognostication. J. Proteome Res. 12, 959–968 (2013).
  Article CAS PubMed Google Scholar
• Rocha, C. M. et al. NMR metabolomics of human lung tumours reveals distinct metabolic signatures for adenocarcinoma and squamous cell carcinoma. Carcinogenesis 36, 68–75 (2014).
  Article PubMed CAS Google Scholar
• Veselkov, K. A. et al. Chemo-informatic strategy for imaging mass spectrometry-based hyperspectral profiling of lipid signatures in colorectal cancer. Proc. Natl Acad. Sci. USA 111, 1216–1221 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Takats, Z., Wiseman, J. M., Gologan, B. & Cooks, R. G. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science 306, 471–473 (2004).
  Article CAS PubMed Google Scholar
• Crecelius, A. C. et al. Three-dimensional visualization of protein expression in mouse brain structures using imaging mass spectrometry. J. Am. Soc. Mass Spectrom. 16, 1093–1099 (2005).
  Article CAS PubMed Google Scholar
• Balluff, B. et al. De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry. J. Pathol. 235, 3–13 (2014).
  Article PubMed CAS Google Scholar
• Veselkov, K. A. et al. Recursive segment-wise peak alignment of biological 1H NMR spectra for improved metabolic biomarker recovery. Anal. Chem. 81, 56–66 (2009).
  Article CAS PubMed Google Scholar
• Vu, T. N. & Laukens, K. Getting your peaks in line: a review of alignment methods for NMR spectral data. Metabolites 3, 259–276 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Crutchfield, C. A. et al. Comprehensive analysis of LC/MS data using pseudocolor plots. J. Am. Soc. Mass Spectrom. 24, 230–237 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Trygg, J., Holmes, E. & Lundstedt, T. Chemometrics in metabonomics. J. Proteome Res. 6, 469–479 (2007).
  Article CAS PubMed Google Scholar
• Madsen, R., Lundstedt, T. & Trygg, J. Chemometrics in metabolomics--a review in human disease diagnosis. Anal. Chim. Acta. 659, 23–33 (2010).
  Article CAS PubMed Google Scholar
• Doeswijk, T. G., Smilde, A. K., Hageman, J. A., Westerhuis, J. A. & van Eeuwijk, F. A. On the increase of predictive performance with high-level data fusion. Anal. Chim. Acta. 705, 41–47 (2011).
  Article CAS PubMed Google Scholar
• Cloarec, O. et al. Evaluation of the orthogonal projection on latent structure model limitations caused by chemical shift variability and improved visualization of biomarker changes in 1H NMR spectroscopic metabonomic studies. Anal. Chem. 77, 517–526 (2005).
  Article CAS PubMed Google Scholar
• Posma, J. M., Robinette, S. L., Holmes, E. & Nicholson, J. K. MetaboNetworks, an interactive Matlab-based toolbox for creating, customizing and exploring sub-networks from KEGG. Bioinformatics 30, 893–895 (2014).
  Article CAS PubMed Google Scholar
• Barupal, D. K. et al. MetaMapp: mapping and visualizing metabolomic data by integrating information from biochemical pathways and chemical and mass spectral similarity. BMC Bioinformatics 13, 99 (2012).
  Article PubMed PubMed Central Google Scholar
• Trygg, J. & Wold, S. O2-PLS, a two-block (X-Y) latent variable regression (LVR) method with an integral OSC filter. J. Chemom. 17, 53–64 (2003).
  Article CAS Google Scholar
• Jayaseelan, K. V. & Steinbeck, C. Building blocks for automated elucidation of metabolites: natural product-likeness for candidate ranking. BMC bioinformatics 15, 234 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Acar, E., Lawaetz, A. J., Rasmussen, M. A. & Bro, R. Structure-revealing data fusion model with applications in metabolomics. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2013, 6023–6026 (2013).
  Google Scholar
• Bro, R. et al. Data fusion in metabolomic cancer diagnostics. Metabolomics 9, 3–8 (2013).
  Article CAS PubMed Google Scholar
• Vaughan, A. A. et al. Liquid chromatography-mass spectrometry calibration transfer and metabolomics data fusion. Anal. Chem. 84, 9848–9857 (2012).
  Article CAS PubMed Google Scholar
• Cloarec, O. et al. Statistical total correlation spectroscopy: an exploratory approach for latent biomarker identification from metabolic 1H NMR data sets. Anal. Chem. 77, 1282–1289 (2005).
  Article CAS PubMed Google Scholar
• Keun, H. C. et al. Heteronuclear 19F-1H statistical total correlation spectroscopy as a tool in drug metabolism: study of flucloxacillin biotransformation. Anal. Chem. 80, 1073–1079 (2008).
  Article CAS PubMed Google Scholar
• Posma, J. M. et al. Subset optimization by reference matching (STORM): an optimized statistical approach for recovery of metabolic biomarker structural information from 1H NMR spectra of biofluids. Anal. Chem. 84, 10694–10701 (2012).
  Article CAS PubMed Google Scholar
• Shariff, M. I. et al. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics. Expert Rev. Gastroenterol. Hepatol. 3, 353–367 (2009).
  Article PubMed Google Scholar
• Wallace, M. C., Preen, D., Jeffrey, G. P. & Adams, L. A. The evolving epidemiology of hepatocellular carcinoma: a global perspective. Expert Rev. Gastroenterol. Hepatol. 9, 765–779 (2015).
  Article CAS PubMed Google Scholar
• Duricova, D., Burisch, J., Jess, T., Gower-Rousseau, C. & Lakatos, P. L. Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. J. Crohns Colitis 8, 1351–1361 (2014).
  Article PubMed Google Scholar
• O'Keefe, S. J. et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat. Commun. 6, 6342 (2015).
  Article CAS PubMed Google Scholar
• Cho, I. & Blaser, M. J. The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 13, 260–270 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Dominguez-Bello, M. G., Blaser, M. J., Ley, R. E. & Knight, R. Development of the human gastrointestinal microbiota and insights from high-throughput sequencing. Gastroenterology 140, 1713–1719 (2011).
  Article CAS PubMed Google Scholar
• Joyce, S. A. & Gahan, C. G. The gut microbiota and the metabolic health of the host. Curr. Opin. Gastroenterol. 30, 120–127 (2014).
  Article CAS PubMed Google Scholar
• Nicholson, J. K. et al. Host-gut microbiota metabolic interactions. Science 336, 1262–1267 (2012).
  Article CAS PubMed Google Scholar
• Pande, C., Kumar, A. & Sarin, S. K. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment. Pharmacol. Ther. 29, 1273–1281 (2009).
  Article CAS PubMed Google Scholar
• Vonlaufen, A., Spahr, L., Apte, M. V. & Frossard, J. L. Alcoholic pancreatitis: a tale of spirits and bacteria. World J. Gastrointest. Pathophysiol. 5, 82–90 (2014).
  Article PubMed PubMed Central Google Scholar
• Mehal, W. Z. The gordian knot of dysbiosis, obesity and NAFLD. Nat. Rev. Gastroenterol. Hepatol. 10, 637–644 (2013).
  Article PubMed Google Scholar
• Swann, J. R. et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc. Natl Acad. Sci. USA 108, 4523–4530 (2011).
  Article CAS PubMed Google Scholar
• Claus, S. P. et al. Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes. Mol. Syst. Biol. 4, 219 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Tlaskalova-Hogenova, H. et al. Microbiome and colorectal carcinoma: insights from germ-free and conventional animal models. Cancer J. 20, 217–224 (2014).
  Article CAS PubMed Google Scholar
• Marcobal, A. et al. A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice. ISME J. 7, 1933–1943 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Swann, J. et al. Gut microbiome modulates the toxicity of hydrazine: a metabonomic study. Mol. Biosyst. 5, 351–355 (2009).
  Article CAS PubMed Google Scholar
• Marchesi, J. R. et al. Towards the human colorectal cancer microbiome. PLoS ONE 6, e20447 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Magnusdottir, S., Ravcheev, D., de Crecy-Lagard, V. & Thiele, I. Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes. Front. Genet. 6, 148 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Raman, M. et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 11, 868–875 (2013).
  Article CAS PubMed Google Scholar
• Kelly, C. R. et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am. J. Gastroenterol. 109, 1065–1071 (2014).
  Article PubMed PubMed Central Google Scholar
• Eiseman, B., Silen, W., Bascom, G. S. & Kauvar, A. J. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 44, 854–859 (1958).
  CAS PubMed Google Scholar
• Gough, E., Shaikh, H. & Manges, A. R. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin. Infect. Dis. 53, 994–1002 (2011).
  Article PubMed Google Scholar
• Weingarden, A. R. et al. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am. J. Physiol. Gastrointest. Liver Physiol. 306, G310–G319 (2014).
  Article CAS PubMed Google Scholar
• Borody, T. J., Brandt, L. J. & Paramsothy, S. Therapeutic faecal microbiota transplantation: current status and future developments. Curr. Opin. Gastroenterol. 30, 97–105 (2014).
  Article PubMed Google Scholar
• Colman, R. J. & Rubin, D. T. Fecal microbiota transplantation as therapy for inflammatory bowel disease: A systematic review and meta-analysis. J. Crohns Colitis 8, 1569–1581 (2014).
  Article PubMed Google Scholar
• Hanauer, S. B. & Sandborn, W. Management of Crohn's disease in adults. Am. J. Gastroenterol. 96, 635–643 (2001).
  Article CAS PubMed Google Scholar
• Seeley, E. H., Washington, M. K., Caprioli, R. M. & M'Koma, A. E. Proteomic patterns of colonic mucosal tissues delineate Crohn's colitis and ulcerative colitis. Proteomics Clin. Appl. 7, 541–549 (2013).
  Article CAS PubMed Google Scholar
• Maus, B. et al. Molecular reclassification of Crohn's disease: a cautionary note on population stratification. PLoS ONE 8, e77720 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Gerich, M. E. & McGovern, D. P. Towards personalized care in IBD. Nat. Rev. Gastroenterol. Hepatol. 11, 287–299 (2014).
  Article CAS PubMed Google Scholar
• Dawiskiba, T. et al. Serum and urine metabolomic fingerprinting in diagnostics of inflammatory bowel diseases. World J. Gastroenterol. 20, 163–174 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Williams, H. R. et al. Serum metabolic profiling in inflammatory bowel disease. Dig. Dis. Sci. 57, 2157–2165 (2012).
  Article CAS PubMed Google Scholar
• Fathi, F. et al. 1H NMR based metabolic profiling in Crohn's disease by random forest methodology. Magn. Reson. Chem. 52, 370–376 (2014).
  Article CAS PubMed Google Scholar
• Kostic, A. D., Xavier, R. J. & Gevers, D. The microbiome in inflammatory bowel disease: current status and the future ahead. Gastroenterology 146, 1489–1499 (2014).
  Article CAS PubMed Google Scholar
• Sartor, R. B. Microbial influences in inflammatory bowel diseases. Gastroenterology 134, 577–594 (2008).
  Article CAS PubMed Google Scholar
• Elliott, P. et al. Urinary metabolic signatures of human adiposity. Sci. Transl. Med. 7, 285ra62 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Shaukat, A. et al. Long-term mortality after screening for colorectal cancer. N. Engl. J. Med. 369, 1106–1114 (2013).
  Article CAS PubMed Google Scholar
• Mirnezami, R. et al. Chemical mapping of the colorectal cancer microenvironment via MALDI imaging mass spectrometry (MALDI-MSI) reveals novel cancer-associated field effects. Mol. Oncol. 8, 39–49 (2014).
  Article CAS PubMed Google Scholar
• Chan, E. C. Y. et al. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J. Proteome Res. 8, 352–361 (2009).
  Article CAS PubMed Google Scholar
• Wang, H. et al. 1H NMR-based metabolic profiling of human rectal cancer tissue. Mol. Cancer 12, 121 (2013).
  Article PubMed PubMed Central Google Scholar
• Zhu, J. et al. Colorectal cancer detection using targeted serum metabolic profiling. J. Proteome Res. 13, 4120–4130 (2014).
  Article CAS PubMed Google Scholar
• Montrose, D. C. et al. Metabolic profiling, a noninvasive approach for the detection of experimental colorectal neoplasia. Cancer Prev. Res. 5, 1358–1367 (2012).
  Article CAS Google Scholar
• Nishiumi, S. et al. A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS ONE 7, e40459 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Ibanez, C. et al. CE/LC-MS multiplatform for broad metabolomic analysis of dietary polyphenols effect on colon cancer cells proliferation. Electrophoresis 33, 2328–2336 (2012).
  Article CAS PubMed Google Scholar
• Tan, B. et al. Metabonomics identifies serum metabolite markers of colorectal cancer. J. Proteome Res. 12, 3000–3009 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Cross, A. J. et al. A prospective study of serum metabolites and colorectal cancer risk. Cancer 120, 3049–3057 (2014).
  Article CAS PubMed Google Scholar
• Silva, C. L., Passos, M. & Camara, J. S. Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry. Br. J. Cancer 105, 1894–1904 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Eisner, R., Greiner, R., Tso, V., Wang, H. & Fedorak, R. N. A machine-learned predictor of colonic polyps based on urinary metabolomics. BioMed Res. Int. 2013, 303982 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Goedert, J. J. et al. Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis 35, 2089–2096 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Phua, L. C. et al. Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol. Ther. 15, 389–397 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Wedemeyer, H., Dore, G. J. & Ward, J. W. Estimates on HCV disease burden worldwide - filling the gaps. J. Viral Hepat. 22 Suppl 1, 1–5 (2015).
  Article PubMed Google Scholar
• Trepo, C., Chan, H. L. & Lok, A. Hepatitis B virus infection. Lancet 384, 2053–2063 (2014).
  Article CAS PubMed Google Scholar
• Gomaa, A. I., Khan, S. A., Toledano, M. B., Waked, I. & Taylor-Robinson, S. D. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J. Gastroenterol. 14, 4300–4308 (2008).
  Article PubMed PubMed Central Google Scholar
• Wiessing, L. et al. Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention. PLoS ONE 9, e103345 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Gomaa, A. I., Hashim, M. S. & Waked, I. Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in egypt. PLoS ONE 9, e90929 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• Kohli, A., Shaffer, A., Sherman, A. & Kottilil, S. Treatment of Hepatitis C: A systematic review. JAMA 312, 631–640 (2014).
  Article CAS PubMed Google Scholar
• Ladep, N. G. & Taylor-Robinson, S. D. Management of liver disease in Nigeria. Clin. Med. 7, 439–441 (2007).
  Article Google Scholar
• Beyoglu, D. & Idle, J. R. The metabolomic window into hepatobiliary disease. J. Hepatol. 59, 842–858 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Dumas, M. E., Kinross, J. & Nicholson, J. K. Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease. Gastroenterology 146, 46–62 (2014).
  Article PubMed Google Scholar
• Cassol, E. et al. Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors. BMC Infect. Dis. 13, 203 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, A. H., Sun, H., Han, Y., Yan, G. L. & Wang, X. J. Urinary metabolic biomarker and pathway study of hepatitis B virus infected patients based on UPLC-MS system. PLoS ONE 8, e64381 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Ladep, N. G. et al. Discovery and validation of urinary metabotypes for the diagnosis of hepatocellular carcinoma in West Africans. Hepatology 60, 1291–1301 (2014).
  Article CAS PubMed Google Scholar
• Bosch, F. X., Ribes, J., Diaz, M. & Cleries, R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 127, S5–S16 (2004).
  Article PubMed Google Scholar
• Patel, M. et al. Hepatocellular carcinoma: diagnostics and screening. J. Eval. Clin. Pract. 18, 335–342 (2012).
  Article PubMed Google Scholar
• Johnson, P. J. Role of alpha-fetoprotein in the diagnosis and management of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 14, S32–S36 (1999).
  Article PubMed Google Scholar
• Farinati, F. et al. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: Both or neither? Am. J. Gastroenterol. 101, 524–532 (2006).
  Article CAS PubMed Google Scholar
• Bedossa, P. & Poynard, T. An algorithm for the grading of activity in chronic hepatitis, C. The METAVIR cooperative study group. Hepatology 24, 289–293 (1996).
  Article CAS PubMed Google Scholar
• Ishak, K. et al. Histological grading and staging of chronic hepatitis. J. Hepatol. 22, 696–699 (1995).
  Article CAS PubMed Google Scholar
• Baranova, A., Lal, P., Birerdinc, A. & Younossi, Z. M. Non-invasive markers for hepatic fibrosis. BMC Gastroenterol. 11, 91 (2011).
  Article PubMed PubMed Central Google Scholar
• Regev, A. et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. 97, 2614–2618 (2002).
  Article PubMed Google Scholar
• de Groen, P. C., Gores, G. J., LaRusso, N. F., Gunderson, L. L. & Nagorney, D. M. Biliary tract cancers. N. Engl. J. Med. 341, 1368–1378 (1999).
  Article CAS PubMed Google Scholar
• Zabron, A., Edwards, R. J. & Khan, S. A. The challenge of cholangiocarcinoma: Dissecting the molecular mechanisms of an insidious cancer. Dis. Model. Mech. 6, 281–292 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Sithithaworn, P., Yongvanit, P., Duenngai, K., Kiatsopit, N. & Pairojkul, C. Roles of liver fluke infection as risk factor for cholangiocarcinoma. J. Hepatobiliary Pancreat. Sci. 21, 301–308 (2014).
  Article PubMed Google Scholar
• Khan, S. A., Thomas, H. C., Davidson, B. R. & Taylor-Robinson, S. D. Cholangiocarcinoma. Lancet 366, 1303–1314 (2005).
  Article PubMed Google Scholar
• Shariff, M. I. et al. Characterization of urinary biomarkers of hepatocellular carcinoma using magnetic resonance spectroscopy in a Nigerian population. J. Proteome Res. 9, 1096–1103 (2010).
  Article CAS PubMed Google Scholar
• Canbakan, B. et al. Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease. Acta Gastroenterol. Belg. 70, 277–284 (2007).
  CAS PubMed Google Scholar
• Dyson, J. K., Anstee, Q. M. & McPherson, S. Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging. Frontline Gastroenterol. 5, 211–218 (2014).
  Article CAS PubMed Google Scholar
• LaBrecque, D. R. et al. World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 48, 467–473 (2014).
  Article PubMed Google Scholar
• Corey, K. E. & Kaplan, L. M. Obesity and liver disease: The epidemic of the twenty-first century. Clin. Liver Dis. 18, 1–18 (2014).
  Article PubMed Google Scholar
• Gomaa, A. I., Khan, S. A., Leen, E. L., Waked, I. & Taylor-Robinson, S. D. Diagnosis of hepatocellular carcinoma. World J. Gastroenterol. 15, 1301–1314 (2009).
  Article PubMed PubMed Central Google Scholar
• Barr, J. et al. Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease. J. Proteome Res. 9, 4501–4512 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Barr, J. et al. Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression. J. Proteome Res. 11, 2521–2532 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Clayton, T. A., Baker, D., Lindon, J. C., Everett, J. R. & Nicholson, J. K. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc. Natl Acad. Sci. USA 106, 14728–14733 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57–63 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Yap, I. K. et al. Metabolome-wide association study identifies multiple biomarkers that discriminate north and south Chinese populations at differing risks of cardiovascular disease: INTERMAP study. J. Proteome Res. 9, 6647–6654 (2010).
  Article CAS PubMed PubMed Central Google Scholar
• Arteaga, C. L. et al. Treatment of HER2-positive breast cancer: Current status and future perspectives. Nat. Rev. Clin. Onc. 9, 16–32 (2012).
  Article CAS Google Scholar
• Gutiu, I. A. et al. Pharmacometabonomics, pharmacogenomics and personalized medicine. Rom. J. Intern. Med. 48, 187–191 (2010).
  CAS PubMed Google Scholar
• Kwon, H. N. et al. Predicting idiopathic toxicity of cisplatin by a pharmacometabonomic approach. Kidney Int. 79, 529–537 (2011).
  Article CAS PubMed Google Scholar
• Nicholson, J. K., Wilson, I. D. & Lindon, J. C. Pharmacometabonomics as an effector for personalized medicine. Pharmacogenomics 12, 103–111 (2011).
  Article CAS PubMed Google Scholar
• Backshall, A., Sharma, R., Clarke, S. J. & Keun, H. C. Pharmacometabonomic profiling as a predictor of toxicity in patients with inoperable colorectal cancer treated with capecitabine. Clin. Cancer Res. 17, 3019–3028 (2011).
  Article CAS PubMed Google Scholar
• Everett, J. R., Loo, R. L. & Pullen, F. S. Pharmacometabonomics and personalized medicine. Ann. Clin. Biochem. 50, 523–545 (2013).
  Article PubMed Google Scholar
• K. C. et al. In vivo, in situ tissue analysis using rapid evaporative ionization mass spectrometry. Angew. Chem. Int. Ed. Engl. 48, 8240–8242 (2009).
  Article CAS Google Scholar
• Balog, J. et al. Intraoperative tissue identification using rapid evaporative ionization mass spectrometry. Sci. Transl. Med. 5, 194ra93 (2013).
  Article PubMed CAS Google Scholar
• Strittmatter, N. et al. Analysis of intact bacteria using rapid evaporative ionisation mass spectrometry. Chem. commun. 49, 6188–6190 (2013).
  Article CAS Google Scholar
• Balog, J. et al. Identification of biological tissues by rapid evaporative ionization mass spectrometry. Anal. Chem. 82, 7343–7350 (2010).
  Article CAS PubMed Google Scholar
• Plichta, J. K. et al. Does practice make perfect? Resident experience with breast surgery influences excision adequacy. Am. J. Surg. 209, 547–551 (2015).
  Article PubMed Google Scholar
• Guenther, S. et al. Spatially resolved metabolic phenotyping of breast cancer by desorption electrospray ionization mass spectrometry. Cancer Res. 75, 1828–1837 (2015).
  Article CAS PubMed Google Scholar
• Nicholson, J. K. & Lindon, J. C. Systems biology: Metabonomics. Nature 455, 1054–1056 (2008).
  Article CAS PubMed Google Scholar
• Lindon, J. C. et al. Summary recommendations for standardization and reporting of metabolic analyses. Nat. Biotechnol. 23, 833–838 (2005).
  Article CAS PubMed Google Scholar
• MRC-NIHR National Phenome Centre [online]
• Dona, A. C. et al. Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping. Anal. Chem. 86, 9887–9894 (2014).
  Article CAS PubMed Google Scholar
• Sarafian, M. H. et al. Objective set of criteria for optimization of sample preparation procedures for ultra-high throughput untargeted blood plasma lipid profiling by ultra performance liquid chromatography-mass spectrometry. Anal. Chem. 86, 5766–5774 (2014).
  Article CAS PubMed Google Scholar
• Human Metabolome Database [online]
• Mirnezami, R. et al. Rapid diagnosis and staging of colorectal cancer via high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy of intact tissue biopsies. Ann. Surg. 259, 1138–1149 (2014).
  Article PubMed Google Scholar
• Cajka, T. & Fiehn, O. Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry. Trends Analyt. Chem. 61, 192–206 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Kurland, I. J. et al. Application of combined omics platforms to accelerate biomedical discovery in diabesity. Ann. N. Y. Acad. Sci. 1287, 1–16 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Nicholson, J. K., Holmes, E., Lindon, J. C. & Wilson, I. D. The challenges of modeling mammalian biocomplexity. Nat. Biotechnol. 22, 1268–1274 (2004).
  Article CAS PubMed Google Scholar
• Biological Magnetic Resonance Data Bank [online]